The Future of Lab Medicine

 

Tune in as Dr. Mahul Amin discusses the evolving landscape of diagnostic testing, the impact of lab medicine on health systems, and future innovations that promise to shape the field, providing valuable insights for healthcare leaders.

<span>Key considerations for advancing true innovation at hospitals and health systems</span>
September 27, 2024

Key considerations for advancing true innovation at hospitals and health systems

In an executive roundtable sponsored by Labcorp, three Labcorp leaders—Deborah Boles, PhD, vice president of research and development; Bryan Vaughn, senior vice president of hospitals and health systems; and Megann Watters, vice president of corporate development, new ventures and strategic alliances—led a discussion on Labcorp's investments in new technology and programs to help health systems reduce costs and optimize care. 
<span>Leading through a lab management transition: Fireside chat with Lugard Igharo, regional lab director and former Ascension employee</span>
May 16, 2024

Leading through a lab management transition: Fireside chat with Lugard Igharo, regional lab director and former Ascension employee

Lu Igharo, regional lab director, Labcorp (formerly Ascension), and Bryan Vaughn, senior vice president of health systems, Labcorp, discuss the Ascension and Labcorp lab management transition process, including the Ascension lab team’s initial reaction to the partnership announcement and how the sentiment has grown to be overwhelmingly positive in the time since. 
February 23, 2024

Central lab capabilities in Japan: Insights from a recent symposium

In this video, Catherine Ohura, VP and general manager at Labcorp laboratories in Japan, alongside Takashi Shibata, site lead for Labcorp Central Laboratories in Japan, provide an overview of Labcorp’s central lab capabilities in Japan. Additionally, Kazuya Kurachi, senior director of global regulatory operations, discusses CDx development in Japan. Discussing the lab’s significant expansions over the years, they detail its steady growth in capabilities. Through a collaboration with BML, the lab is set to grow even further by 2025. The facility’s expanded offerings will include flow cytometry, immunology, and anatomic pathology and histology.